Search

everythinglearnresearchcommunity

for

Search:↓

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Adipose-derived stem cells can help repair and improve eye tissues and appearance.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Scientists made nanoparticles from human hair proteins to improve drug delivery.

The YH complex, made from Astragalus membranaceus and Cinnamomum cassia, may help treat hair loss by promoting hair growth and follicle development.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

Most men using teledermatology for hair loss treatment saw improved hair and self-esteem, with some experiencing side effects.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

New tools were created to help lupus patients report their symptoms and impacts more accurately.

Patients generally feel positive about alopecia areata treatments, but emotions vary by treatment type.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Patients with psoriasis ranked symptom control and treatment efficacy as most important for their care.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

Hirsutism treatment should focus more on patient needs and quality of life.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Both endoscopic and pretrichial open forehead lifts effectively elevate eyebrows long-term with high patient satisfaction.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.